Aglaia Oncology Fund II is a closed private equity fund managed by AGLAIA BioMedical Ventures BV.
Biopharmaceutical company InteRNA Technologies has raised $10.5m in Series A funding from INKEF Capital and Aglaia Oncology Fund II.
Read more news concerning Aglaia Oncology Fund II
AGLAIA BioMedical Ventures BV is a private equity general partner firm headquartered in Bilthoven, Netherlands.
View full profile
Registration is fast, free and easy
Already a member?